Dual COX/5-LOX inhibition by isorhamnetin-3-O-glucoside from Anthyllis cytisoides: An integrated chemical-enzymatic-computational study
View/ Open
Publisher version (Check access options)
Check access options
Date
2026-03-01Author
Bouammali, HaythamKhibech, Oussama
Fraj, Elmehdi
Elbouzidi, Amine
Bekkouch, Ayoub
Bourhou, Chaymae
Zughaier, Susu M.
Merzouki, Mohammed
Hassiba, Maryam
jaouani, Hanane
Bouammali, Boufelja
Challioui, Allal
Touzani, Rachid
...show more authors ...show less authors
Metadata
Show full item recordAbstract
Ethnopharmacological relevanceAnthyllis cytisoides L. is a forage shrub native to the western Mediterranean basin, traditionally used in folk medicine to treat respiratory and gastrointestinal inflammation. However, its polar phytochemical profile and the underlying enzyme-level anti-inflammatory mechanisms involving COX-1/COX-2 and 5-LOX remain weakly documented. Aim of the studyTo integrate chemical, enzymatic, and computational evidence that links the constituents of A. cytisoides L to COX-1, COX-2, and 5-LOX targets, thereby contextualizing the species’ ethnopharmacological indications. Materials and methodsThe aerial parts were subjected to polarity-guided fractionation followed by LC–HRMS profiling. From the methanolic fraction, a flavonol glycoside was isolated and structurally elucidated as isorhamnetin-3-O-glucoside (I3OG) using ESI–MS, IR spectroscopy, and 1D/2D NMR analyses. Enzymatic inhibition of COX-1, COX-2, and 5-LOX was assessed (COX via PGE2 radioimmunoassay; 5-LOX via FOX assay at 560 nm), and IC50 values were calculated using four-parameter logistic regression (95 % CI). Molecular docking (COX-1: 1EQG; COX-2: 5F19; 5-LOX: 6NCF) and 100-ns molecular dynamics simulations (GROMACS) were also performed. ResultsI3OG was successfully identified and purified from A. cytisoides. It inhibited COX-1, COX-2, and 5-LOX with IC50 values of 10.65 ± 1.02, 15.09 ± 0.84, and 15.24 ± 1.18 μg/mL (≈22.3, 31.6, and 31.9 μM), respectively, surpassing the inhibitory activity of the crude extracts for all targets. Docking studies and 100-ns MD simulations confirmed stable interactions with each enzyme, in agreement with the experimental inhibition ranking (COX-1 > COX-2 ≈ 5-LOX). ConclusionI3OG emerges as a promising dual COX/5-LOX candidate from A. cytisoides, providing a coherent link between detailed phytochemical analysis, enzymatic inhibition, and atomistic binding mechanisms. Although selectivity and safety considerations fall outside the scope of this enzyme-focused study, the findings highlight A. cytisoides as a valuable source of multitarget anti-inflammatory scaffolds and support SAR-driven optimization and formulation strategies aimed at enhancing bioactivity.
Collections
- Medicine Research [2051 items ]

